[1]
2023. Analysis of combination therapy with SGLT2 and DPP4 inhibitors in patients with Type 2 Diabetes Mellitus: an integrative review. Electronic Journal Collection Health. 23, 5 (May 2023), e12495. DOI:https://doi.org/10.25248/reas.e12495.2023.